These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 10657369)

  • 41. Quantitative determination of plasma c8-c26 total fatty acids for the biochemical diagnosis of nutritional and metabolic disorders.
    Lagerstedt SA; Hinrichs DR; Batt SM; Magera MJ; Rinaldo P; McConnell JP
    Mol Genet Metab; 2001 May; 73(1):38-45. PubMed ID: 11350181
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetic and cellular modifiers of oxidative stress: what can we learn from fatty acid oxidation defects?
    Olsen RK; Cornelius N; Gregersen N
    Mol Genet Metab; 2013; 110 Suppl():S31-9. PubMed ID: 24206932
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical and biochemical monitoring of patients with fatty acid oxidation disorders.
    Lund AM; Skovby F; Vestergaard H; Christensen M; Christensen E
    J Inherit Metab Dis; 2010 Oct; 33(5):495-500. PubMed ID: 20066495
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency.
    Tyni T; Pihko H
    Acta Paediatr; 1999 Mar; 88(3):237-45. PubMed ID: 10229030
    [TBL] [Abstract][Full Text] [Related]  

  • 45. New developments in the diagnosis and investigation of mitochondrial fatty acid oxidation disorders.
    Coates PM
    Eur J Pediatr; 1994; 153(7 Suppl 1):S49-56. PubMed ID: 7957387
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Human trifunctional protein deficiency: a new disorder of mitochondrial fatty acid beta-oxidation.
    Wanders RJ; IJlst L; Poggi F; Bonnefont JP; Munnich A; Brivet M; Rabier D; Saudubray JM
    Biochem Biophys Res Commun; 1992 Nov; 188(3):1139-45. PubMed ID: 1445348
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children.
    Bonnet D; Martin D; Pascale De Lonlay ; Villain E; Jouvet P; Rabier D; Brivet M; Saudubray JM
    Circulation; 1999 Nov; 100(22):2248-53. PubMed ID: 10577999
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Variation of long-chain 3-hydroxyacyl-CoA dehydrogenase DNA methylation in placenta of different preeclampsia-like mouse models].
    Han Y; Yang Z; Ding X; Yu H; Yi Y
    Zhonghua Fu Chan Ke Za Zhi; 2015 Oct; 50(10):740-6. PubMed ID: 26675572
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Determination of total fatty acids in plasma: cis-5-tetradecenoic acid (C14:1 omega-9) in the diagnosis of long-chain fatty acid oxidation defects.
    Divry P; Vianey-Saban C; Mathieu M
    J Inherit Metab Dis; 1999 May; 22(3):286-8. PubMed ID: 10384388
    [No Abstract]   [Full Text] [Related]  

  • 50. Inborn errors of metabolism diagnosed in sudden death cases by acylcarnitine analysis of postmortem bile.
    Rashed MS; Ozand PT; Bennett MJ; Barnard JJ; Govindaraju DR; Rinaldo P
    Clin Chem; 1995 Aug; 41(8 Pt 1):1109-14. PubMed ID: 7628085
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Early neonatal diagnosis of long-chain 3-hydroxyacyl coenzyme a dehydrogenase and mitochondrial trifunctional protein deficiencies.
    Hintz SR; Matern D; Strauss A; Bennett MJ; Hoyme HE; Schelley S; Kobori J; Colby C; Lehman NL; Enns GM
    Mol Genet Metab; 2002 Feb; 75(2):120-7. PubMed ID: 11855930
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quantitative analysis of urinary acylglycines for the diagnosis of beta-oxidation defects using GC-NCI-MS.
    Costa CG; Guérand WS; Struys EA; Holwerda U; ten Brink HJ; Tavares de Almeida I; Duran M; Jakobs C
    J Pharm Biomed Anal; 2000 Jan; 21(6):1215-24. PubMed ID: 10708405
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mitochondrial fatty acid oxidation disorders and cyclic vomiting syndrome.
    Rinaldo P
    Dig Dis Sci; 1999 Aug; 44(8 Suppl):97S-102S. PubMed ID: 10490047
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pigmentary retinopathy in long chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency.
    Lawlor DP; Kalina RE
    Am J Ophthalmol; 1997 Jun; 123(6):846-8. PubMed ID: 9535636
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diagnosis of mitochondrial fatty acid oxidation defects.
    Duran M; Bruinvis L; Ketting D; Dorland L
    Padiatr Padol; 1993; 28(1):19-25. PubMed ID: 8446424
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mitochondrial dysfunction in fatty acid oxidation disorders: insights from human and animal studies.
    Wajner M; Amaral AU
    Biosci Rep; 2015 Nov; 36(1):e00281. PubMed ID: 26589966
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 3-Hydroxyacyl-CoA dehydrogenase and short chain 3-hydroxyacyl-CoA dehydrogenase in human health and disease.
    Yang SY; He XY; Schulz H
    FEBS J; 2005 Oct; 272(19):4874-83. PubMed ID: 16176262
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inborn Errors of Long-Chain Fatty Acid β-Oxidation Link Neural Stem Cell Self-Renewal to Autism.
    Xie Z; Jones A; Deeney JT; Hur SK; Bankaitis VA
    Cell Rep; 2016 Feb; 14(5):991-999. PubMed ID: 26832401
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mitochondropathy presenting with non-ketotic hypoglycaemia as 3-hydroxydicarboxylic aciduria.
    Mayatepek E; Wanders RJ; Becker M; Bremer HJ; Hoffmann GF
    J Inherit Metab Dis; 1995; 18(2):249-52. PubMed ID: 7564260
    [No Abstract]   [Full Text] [Related]  

  • 60. A case report of short-chain acyl-CoA dehydrogenase deficiency (SCADD).
    Lampret BR; Murko S; Debeljak M; Tansek MZ; Fister P; Battelino T
    Biochem Med (Zagreb); 2015; 25(2):279-84. PubMed ID: 26110041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.